Barlita, Marjorie .

HRN: 22-60-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2023
CEFUROXIME 500MG (TAB)
04/23/2023
04/29/2023
PO
500MG
BID
Threatened Preterm Labor
Waiting Final Action 
05/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/14/2023
05/14/2023
IV
500mg
Now
Primary LTCS
Waiting Final Action 
05/14/2023
CEFUROXIME 1.5GM (VIAL)
05/14/2023
05/15/2023
IV
1.5gram
Q 8hrs X 3 Doses
Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: